{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:23:19Z","timestamp":1774786999583,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.03.070","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T13:29:30Z","timestamp":1208352570000},"page":"5170-5176","source":"Crossref","is-referenced-by-count":17,"title":["HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1\/Th2-type immune response"],"prefix":"10.1016","volume":"26","author":[{"given":"Elizaveta S.","family":"Starodubova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Litvina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Morozov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia V.","family":"Petrakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Timofeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Latyshev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Tunitskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Wahren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Isaguliants","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim L.","family":"Karpov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.vaccine.2008.03.070_bib1","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/00002030-199816000-00007","article-title":"HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons","volume":"12","author":"Bernard","year":"1998","journal-title":"AIDS"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2008.03.070_bib2","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/00002030-200216004-00014","article-title":"Early and late cytotoxic T lymphocyte responses in HIV infection","volume":"16","author":"Brander","year":"2002","journal-title":"AIDS"},{"issue":"14\/15","key":"10.1016\/j.vaccine.2008.03.070_bib3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0264-410X(98)00102-9","article-title":"Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV","volume":"16","author":"Riviere","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.070_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4049\/jimmunol.162.2.639","article-title":"Cutting edge: induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen","volume":"162","author":"Tobery","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.03.070_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.03.070_bib6","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4161\/cc.4.11.2115","article-title":"Mechanisms of protein degradation: an odyssey with ODC","volume":"4","author":"Kahana","year":"2005","journal-title":"Cell Cycle"},{"issue":"6404","key":"10.1016\/j.vaccine.2008.03.070_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/360597a0","article-title":"Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination","volume":"360","author":"Murakami","year":"1992","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2008.03.070_bib8","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1128\/MCB.13.4.2377","article-title":"Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein","volume":"13","author":"Li","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.03.070_bib9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/emboj\/cdg158","article-title":"Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.070_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/088922204773004914","article-title":"Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase","volume":"20","author":"Isaguliants","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"21","key":"10.1016\/j.vaccine.2008.03.070_bib11","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2005.08.020","article-title":"HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1","volume":"24","author":"Starodubova","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.070_bib12","first-page":"1248","article-title":"Reverse transcriptase of the human immunodeficiency virus: cloning, expression in Escherichia coli, purification of the enzyme, and production of monoclonal antibodies","volume":"25","author":"Rechinskii","year":"1991","journal-title":"Mol Biol (Mosk)"},{"issue":"2-3","key":"10.1016\/j.vaccine.2008.03.070_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-5793(99)00297-5","article-title":"Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase","volume":"447","author":"Isaguliants","year":"1999","journal-title":"FEBS Lett"},{"issue":"21","key":"10.1016\/j.vaccine.2008.03.070_bib14","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/j.vaccine.2007.02.058","article-title":"Combined virus-like particle-based polyepitope DNA\/protein HIV-1 vaccine design, immunogenicity and toxicity studies","volume":"25","author":"Karpenko","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.070_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/hum.1997.8.3-293","article-title":"Do DNA vaccines induce autoimmune disease?","volume":"8","author":"Mor","year":"1997","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2008.03.070_bib16","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1074\/jbc.271.8.4441","article-title":"The N terminus of antizyme promotes degradation of heterologous proteins","volume":"271","author":"Li","year":"1996","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2008.03.070_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","article-title":"PEST sequences and regulation by proteolysis","volume":"21","author":"Rechsteiner","year":"1996","journal-title":"Trends Biochem Sci"},{"issue":"1-3","key":"10.1016\/j.vaccine.2008.03.070_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbamcr.2004.09.025","article-title":"Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach","volume":"1695","author":"Groll","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.070_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","article-title":"Proteasome inhibitors: valuable new tools for cell biologists","volume":"8","author":"Lee","year":"1998","journal-title":"Trends Cell Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.03.070_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/protein\/12.12.1035","article-title":"Attenuation of green fluorescent protein half-life in mammalian cells","volume":"12","author":"Corish","year":"1999","journal-title":"Protein Eng"},{"issue":"17","key":"10.1016\/j.vaccine.2008.03.070_bib21","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1016\/S0021-9258(18)99150-7","article-title":"The C terminus of mouse ornithine decarboxylase confers rapid degradation on dihydrofolate reductase. Support for the pest hypothesis","volume":"266","author":"Loetscher","year":"1991","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2008.03.070_bib22","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1128\/IAI.68.6.3097-3102.2000","article-title":"DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity","volume":"68","author":"Delogu","year":"2000","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.03.070_bib23","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1128\/JVI.71.11.8497-8503.1997","article-title":"DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction","volume":"71","author":"Rodriguez","year":"1997","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.070_bib24","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pone.0000135","article-title":"DNA encoding an HIV-1Gag\/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques","volume":"27","author":"Chikhlikar","year":"2006","journal-title":"PLoS ONE"},{"issue":"21","key":"10.1016\/j.vaccine.2008.03.070_bib25","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1016\/j.vaccine.2005.08.026","article-title":"Plasmid-encoded GM-CSF induces priming of the F4(K88)-specific serum IgA response by FaeG DNA vaccination in pigs","volume":"24","author":"Melkebeek","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.03.070_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1566524033479852","article-title":"The role of mucosal immunity in prevention of HIV transmission","volume":"3","author":"Kozlowski","year":"2003","journal-title":"Curr Mol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.070_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2796.2007.01822.x","article-title":"Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women","volume":"262","author":"Hirbod","year":"2007","journal-title":"J Intern Med"},{"issue":"4\u20136","key":"10.1016\/j.vaccine.2008.03.070_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000053996","article-title":"DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge","volume":"43","author":"Isaguliants","year":"2000","journal-title":"Intervirology"},{"issue":"13-14","key":"10.1016\/j.vaccine.2008.03.070_bib29","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.vaccine.2003.09.047","article-title":"Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cells","volume":"22","author":"Isaguliants","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.070_bib30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.174.2.718","article-title":"T cells undergo rapid ON\/OFF but not ON\/OFF\/ON cycling of cytokine production in response to antigen","volume":"174","author":"Corbin","year":"2005","journal-title":"J Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2008.03.070_bib31","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1089\/088922200750054747","article-title":"Intranasal immunization with HIV reverse transcriptase: effect of dose in the induction of helper T cell type 1 and 2 immunity","volume":"16","author":"Pacheco","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2008.03.070_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.0105-2896.2004.0135.x","article-title":"Targeting plasmid-encoded proteins to the antigen presentation pathways","volume":"199","author":"Leifert","year":"2004","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.070_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00705-005-0676-9","article-title":"Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses","volume":"151","author":"Altstein","year":"2006","journal-title":"Arch Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T19:47:51Z","timestamp":1684352871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":33,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X08003356"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}